Type 1 interferons and antiviral CD8 T-cell responses. - Wikidata - awgldk - TriplyDB

Type 1 interferons and antiviral CD8 T-cell responses.

Type 1 interferons and antiviral CD8 T-cell responses.

http://www.wikidata.org/entity/Q34126296

about

MicroRNAs Expressed during Viral Infection: Biomarker Potential and Therapeutic Considerations Immune and non-immune responses to hepatitis C virus infection Decoding the complexity of type I interferon to treat persistent viral infections Disease-promoting effects of type I interferons in viral, bacterial, and coinfections STAT2 deficiency and susceptibility to viral illness in humans RIG-I Signaling Is Critical for Efficient Polyfunctional T Cell Responses during Influenza Virus Infection Type I interferon suppresses de novo virus-specific CD4 Th1 immunity during an established persistent viral infection.Unraveling the convoluted biological roles of type I interferons in infection and immunity: a way forward for therapeutics and vaccine design.Distinct dictation of Japanese encephalitis virus-induced neuroinflammation and lethality via triggering TLR3 and TLR4 signal pathways.Out-of-sequence signal 3 as a mechanism for virus-induced immune suppression of CD8 T cell responses.IRF-3, IRF-5, and IRF-7 coordinately regulate the type I IFN response in myeloid dendritic cells downstream of MAVS signaling Link between chronic inflammation and human papillomavirus-induced carcinogenesis (Review).Functional limitations of plasmacytoid dendritic cells limit type I interferon, T cell responses and virus control in early life.Human pDCs preferentially sense enveloped hepatitis A virions.Type I interferons regulate eomesodermin expression and the development of unconventional memory CD8(+) T cells.Targeting polyIC to EGFR over-expressing cells using a dsRNA binding protein domain tethered to EGF.Amelioration of Japanese encephalitis by blockage of 4-1BB signaling is coupled to divergent enhancement of type I/II IFN responses and Ly-6C(hi) monocyte differentiation.CD8+ T cell-derived IFN-γ prevents infection by a second heterologous virus.Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice.Anti-viral CD8 T cells and the cytokines that they love Type I interferons in viral control and immune regulation Type 1 interferon licenses naïve CD8 T cells to mediate anti-viral cytotoxicity Networking at the level of host immunity: immune cell interactions during persistent viral infections Interferon regulatory factor 3 is a key regulation factor for inducing the expression of SAMHD1 in antiviral innate immunity.Innate immunity regulates adaptive immune response: lessons learned from studying the interplay between NK and CD8+ T cells during MCMV infection The impact of macroautophagy on CD8(+) T-cell-mediated antiviral immunity.Regulation of antiviral CD8 T-cell responses Monocyte/macrophage inflammatory response pathways to combat Francisella infection: possible therapeutic targets?Staying alive: cell death in antiviral immunity.Hybrid approach to model the spatial regulation of T cell responses.Response of hepatitis C virus to long-term passage in the presence of alpha interferon: multiple mutations and a common phenotype.The Protective Role of Type I Interferons in the Gastrointestinal Tract.Plasmacytoid and conventional dendritic cells cooperate in crosspriming AAV capsid-specific CD8+ T cells.Nonreversible MAIT cell-dysfunction in chronic hepatitis C virus infection despite successful interferon-free therapy.Type I Interferon Is a Catastrophic Feature of the Diabetic Islet Microenvironment Reduced interferon-α production by dendritic cells in type 1 diabetes does not impair immunity to influenza virus.Type I interferon signaling enhances CD8+ T cell effector function and differentiation during murine gammaherpesvirus 68 infection.Efficient Targeting and Activation of Antigen-Presenting Cells In Vivo after Modified mRNA Vaccine Administration in Rhesus Macaques.T-cell immunity and hepatitis C virus reinfection after cure of chronic hepatitis C with an interferon-free antiviral regimen in a chimpanzee.A robust microparticle platform for a STING-targeted adjuvant that enhances both humoral and cellular immunity during vaccination.

P2860

Q26773183-2CAEB85E-20B9-498C-BA7A-C1C62FA51E88 Q26782040-C1487554-CE4B-43C3-B43F-22F62D2A0A2E Q27023801-C01715FF-1F8E-4950-8ED9-B3151743F1DC Q28082841-25D4E976-EA8D-4CE0-94B8-05A1AB3EA88E Q28115608-CB971C3E-FD7A-4D80-89B7-AD0C0E6C6CFD Q30390782-AB1E63AE-8885-4F9F-B04D-16F7608CD8FC Q33665625-A5E00C19-2566-47EF-B88D-A2B6145F0853 Q34106393-CA671812-3E94-4C27-A029-BADB21F6C4DA Q34134217-3458163D-0794-4473-B4AB-4BBA46989FDD Q34257444-8BA90FED-5FFD-44A8-8AE4-7467F8915B99 Q34539832-C13896E7-2722-4793-B783-55F5B2AFF262 Q35042272-224F0C20-2962-4CCD-ACD3-3130F0B824A4 Q35078558-75AAFFD7-DF08-4204-9418-68AB22783A42 Q35242599-B3841B4F-6490-4477-A5BF-28E70F4351A4 Q35608970-1C4F4E8F-5637-4EEC-9AD8-21F0DE8521F7 Q36123983-50753EA0-5B52-4075-BEA6-093ABF681286 Q36310630-B48FFD6C-57DD-4DF0-B7B1-153B74F546E1 Q36456970-B68FDF3F-4963-42D4-B8AB-9A84173CC331 Q36577616-22EDAD3B-BC17-46FD-9514-2F29BB40CA9B Q36634580-D991EA51-103D-46CB-A93A-F571F604B0DB Q36767643-6D200626-C3CC-48B6-80F9-D82D720A5225 Q36880390-7A2F2CA6-71F0-440D-9597-491BAB9F3F17 Q37020616-C24D3CB2-7DD4-4044-BDE2-F4F12AEEF2C1 Q37093160-7D926FC3-4357-4CD5-B092-F11508F3019A Q38042327-FB58E591-11CA-440C-968F-71BC500E3275 Q38129080-13962BEA-79C2-4D79-833C-E3EFB7C9BC13 Q38165191-E207AF15-16C7-4169-A200-8DDC5400E3BD Q38193822-30D5895C-218F-463B-9779-62BBAB4F3DB7 Q38207187-A848940B-9AFD-4027-B7FA-64C03D7D0231 Q38691525-09C9A36B-A5D4-4CFC-A88C-E5394AF253D6 Q39157496-E09E8856-3772-4815-BD9B-9262F1B45781 Q39253724-A24FBB31-0680-440C-97B7-497764F61D39 Q40216716-6187DDCB-64F1-4B2A-8567-C718E3FCF83A Q40703746-9E93ABB7-608C-470A-B53C-D3D645992DA6 Q41672962-D3E3ABAB-FBE2-42F5-BD3E-641AEE83E85E Q41714272-BF550F7C-809C-43D9-B947-AEB0D134B97A Q41727151-E9124408-2AA1-4650-96FD-B063EA740BBB Q41993335-1752F9CD-C4A7-4C13-9EEC-E7774231E9DE Q42061089-E402DB7B-500C-4EAE-A7CF-6AEA6C9E5E6C Q47573396-73FB66DD-4AAD-46FF-BA38-22FDEB03BEDB

P2860

Type 1 interferons and antiviral CD8 T-cell responses.

http://www.wikidata.org/entity/Q34126296

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Type 1 interferons and antiviral CD8 T-cell responses.

@ast

Type 1 interferons and antiviral CD8 T-cell responses.

@en

Type 1 interferons and antiviral CD8 T-cell responses.

@nl

type

label

Type 1 interferons and antiviral CD8 T-cell responses.

@ast

Type 1 interferons and antiviral CD8 T-cell responses.

@en

Type 1 interferons and antiviral CD8 T-cell responses.

@nl

prefLabel

Type 1 interferons and antiviral CD8 T-cell responses.

@ast

Type 1 interferons and antiviral CD8 T-cell responses.

@en

Type 1 interferons and antiviral CD8 T-cell responses.

@nl

P1433

Q34126296-02DB477A-6714-47F6-A54D-31C31F962D13

P1476

Q34126296-C032EE9E-5CE4-46D7-9771-03E07F40B660

P2093

Q34126296-83EA61B0-D3DC-42F2-B23D-D99E5A5FACEC

Q34126296-85C520A2-B7FC-4620-A4ED-179842C01650

Q34126296-D80F8E89-E9C3-4B9F-9238-439C120F3EA6

Q34126296-EC1B2C34-6C4B-4730-8F0B-89D474059968

P275

Q34126296-FF43C103-A5E6-4304-B2E8-10CAFE3935A0

P2860

Q34126296-0B8F7FD1-F596-4D91-AC4D-AE5DA873A34C

Q34126296-1AEF2B7F-8C0D-4EFB-863F-15410C9C6262

Q34126296-1DCB4372-97E5-4754-9CAE-134DB0EA494F

Q34126296-2C5C626C-809A-4516-8F14-F69BFB94D075

Q34126296-316A6FC1-F6EB-4727-B429-36DCFCF374B1

Q34126296-317E0DEA-7B8A-4245-AA8F-E08115ED6CB5

Q34126296-318A0719-26F8-48D7-90C1-62AC36E5BE98

Q34126296-467C4EDD-E040-408E-B0E6-4BF917C40973

Q34126296-48151BBC-837C-4E94-BD93-00777C624151

Q34126296-51C54D49-0FFD-496A-8ACB-14F4EC259910

P304

Q34126296-21B5DD5E-0BDA-47A0-A389-E9E1F712CF19

P31

Q34126296-45351993-F2AE-45AF-9FBF-C79063AA3A8D

Q34126296-F984AC2E-5920-4B13-B3A3-2BAFF9216EFA

P356

Q34126296-B5CF3059-517F-4A8B-8F6A-BD59A173002C

P433

Q34126296-9B98EEB8-16D7-4A42-8105-268D4D231319

P478

Q34126296-71D0F563-1624-46F1-B7EF-5721292EFBB3

P5008

Q34126296-E0F2703C-ECFE-48AC-90BD-B8040214986B

P577

Q34126296-6265CC55-A1E7-4547-A597-01B6A9F1DDA5

Q34126296-F141A9DC-2485-4EE5-9DE5-8E50808868D2

P5875

Q34126296-3498C907-5F8D-4149-A1BC-C0D4202D0635

P698

Q34126296-D735807E-7461-4C5B-8D62-9B844AABD087

P921

Q34126296-3D6D1D1A-941B-4F8C-983D-323C867CC776

Q34126296-3F0C9727-F3B7-459E-BE6E-AE7FDDCF1736

Q34126296-864B6FA4-96E1-451E-9090-122FBDE3BBD6

Q34126296-DA8BF45F-15C8-44C2-860C-DB372EBEBF78

Q34126296-FDC3EBA1-225D-4D95-B678-2CDA374BB200

P932

Q34126296-35EB31CB-58A7-448D-B87B-9256DA86EAF5

P356

JOURNAL.PPAT.1002352

P1433

P1476

Type 1 interferons and antiviral CD8 T-cell responses.

@en

P2093

Heather D Marshall

http://www.w3.org/2001/XMLSchema#string

Kapil Bahl

http://www.w3.org/2001/XMLSchema#string

Raymond M Welsh

http://www.w3.org/2001/XMLSchema#string

Stina L Urban

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Functional role of type I and type II interferons in antiviral defense

The human interferon alpha/beta receptor: characterization and molecular cloning

T cell homeostatic proliferation elicits effective antitumor autoimmunity

Control of effector CD8+ T cell function by the transcription factor Eomesodermin

Two interferon-induced nuclear factors bind a single promoter element in interferon-stimulated genes.

Analysis of apoptosis of memory T cells and dendritic cells during the early stages of viral infection or exposure to toll-like receptor agonists.

Attrition of bystander CD8 T cells during virus-induced T-cell and interferon responses

Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin.

Mechanism of apoptosis induced by IFN-alpha in human myeloma cells: role of Jak1 and Bim and potentiation by rapamycin.

Cutting edge: attrition of Plasmodium-specific memory CD8 T cells results in decreased protection that is rescued by booster immunization.

P304

e1002352

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PPAT.1002352

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2012-01-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221744667

http://www.w3.org/2001/XMLSchema#string

P698

22241987

http://www.w3.org/2001/XMLSchema#string

P921

viral infectious disease

hemic and immune systems

P932

3252364

http://www.w3.org/2001/XMLSchema#string